510(k) Report

510(k) · Cleared

Cleared

Reverse 021 Micro Catheter, Reverse 027 Micro Catheter

K171268510(k) TraditionalCleared May 31, 201730-day reviewClass II21 CFR 870.1250

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Micro Therapeutics, Inc. d/b/a ev3 Neurovascular · DQY Catheter, Percutaneous

Cleared on May 31, 2017 as substantially equivalent to K130858 (Reverse Medical Corporation, 2013) after a 30-day review. Its family tree reaches back 7 generations to 1996.

Decided
May 31, 2017
Review
30 days
Class
Class II
Product code
DQY
Recalls
None
Predicates
1

Its longest line of descent runs back 7 generations to K960806 (1996). 13 ancestors in all, the oldest K925813 (1994). No later device cites it as a predicate yet.

  1. Root · 7 generations backK960806 Turbo TrackerTarget Therapeutics · 1996
  2. 6 generations backK994155 Excelsior 1018 MicrocatheterBoston Scientific, Target · 2000
  3. 5 generations backK013789 Excelsior SL-10 Microcatheter, Models 168581, 168381, 168181, 168189Boston Scientific, Target · 2001 · Recalled
  4. 4 generations backK083343 Headway 17 MicrocatheterMicroVention, Inc. · 2008
  5. 3 generations backK093160 Headway 21 Microcatheter, Model: MC212150SMicroVention, Inc. · 2009
  6. 2 generations backK110813 Headway 27 MicrocatheterMicroVention, Inc. · 2011
  7. 1 generation backK130858 Reverse Medical MicrocatheterReverse Medical Corporation · 2013
  8. This deviceK171268 Reverse 021 Micro Catheter, Reverse 027 Micro CatheterMicro Therapeutics, Inc. d/b/a ev3 Neurovascular · 2017
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−7K960806Turbo TrackerTarget Therapeutics1996—
−6K994155Excelsior 1018 MicrocatheterBoston Scientific, Target2000—
−5K013789Excelsior SL-10 Microcatheter, Models 168581, 168381, 168181, 168189Boston Scientific, Target20012
−4K083343Headway 17 MicrocatheterMicroVention, Inc.2008—
−3K093160Headway 21 Microcatheter, Model: MC212150SMicroVention, Inc.2009—
−2K110813Headway 27 MicrocatheterMicroVention, Inc.2011—
−1K130858Reverse Medical MicrocatheterReverse Medical Corporation2013—
0 (this device)K171268Reverse 021 Micro Catheter, Reverse 027 Micro CatheterMicro Therapeutics, Inc. d/b/a ev3 Neurovascular2017—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199410
200020
200410
201220
FIG. 1 — Lineage of K171268, 1996–2017Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DQY? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DQY device

  1. #1 K234115 APRO 55 Catheterscore 17.5 · 6 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K130858Reverse Medical Microcatheter
Summary page 4
…(DQO) has been classified as Class II per 21 CFR 870.1200 Predicate Reverse™ Medical K130858 11-Oct-2013 Device Microcatheter Reference Navien™ Intracranial Catheter K161152 12-O…
Reverse Medical Corporation2013—
†K161152Navien Intracranial Support CatheterMicro Therapeutics, Inc. d/b/a ev3 Neurovascular2016—
†K150107Arc Intracranial Support Catheter, Arc Mini Intracranial Support CatheterMicro Therapeutics Inc Dba Ev3 Neurovascular2015—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 21 years and passes through 5 companies; a new generation was cleared every 2.2 years on median.
  • 4 of the 13 ancestors have a recall of any class.

How does its category compare?

All DQY devices

DQY Catheter, Percutaneous: FDA decisions, review times, recalls and adverse event reports over 20 years. 2017, this device’s year, is highlighted.

FDA decisions per year · DQY

21in 2025

2007: 162008: 312009: 372010: 222011: 362012: 302013: 322014: 192015: 272016: 222017: 262018: 252019: 302020: 202021: 182022: 182023: 182024: 162025: 212026 (partial year): 11
2007high 37 (2009) · low 16 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DQY

115in 2025

2007: 85 days median2008: 66 days median2009: 73 days median2010: 74 days median2011: 71 days median2012: 87 days median2013: 92 days median2014: 127 days median2015: 118 days median2016: 117 days median2017: 113 days median2018: 106 days median2019: 111 days median2020: 120 days median2021: 81 days median2022: 74 days median2023: 114 days median2024: 87 days median2025: 115 days median2026 (partial year): 30 days median
2007high 127 (2014) · low 66 (2008)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · DQY

1in 2025

2007: 62008: 122009: 172010: 322011: 62012: 22013: 36, 1 Class I2014: 32015: 32016: 22, 7 Class I2017: 82018: 22019: 12020: 22021: 22023: 172024: 12025: 1, 1 Class I2026 (partial year): 2, 1 Class I
2007high 36 (2013) · low 0 (2022)2026

Class I (10 since 2007) Class II/III not classified

Adverse event reports per year · DQY

3,056in 2025

2007: 3132008: 4962009: 8192010: 1,2932011: 1,2112012: 1,1912013: 1,3522014: 1,4972015: 2,3372016: 2,2522017: 2,4892018: 2,8552019: 2,9022020: 2,8892021: 3,0062022: 2,6432023: 3,0492024: 3,1902025: 3,056
2007high 3,190 (2024) · low 313 (2007)2025

MAUDE reports naming product code DQY, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200716856313
2008316612496
2009377317819
20102274321,293
2011367161,211
2012308721,191
2013329236 (1)1,352
20141912731,497
20152711832,337
20162211722 (7)2,252
20172611382,489
20182510622,855
20193011112,902
20202012022,889
2021188123,006
2022187402,643
202318114173,049
2024168713,190
2025211151 (1)3,056
202611302 (1)—

What is it indicated for?

The Reverse™ Micro Catheter is intended for use in neuro, peripheral, and coronary vasculature for the infusion of diagnostic agents, such as contrast media, and therapeutic agents, such as occlusion coils.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K171268: Reverse 021 Micro Catheter, Reverse 027 Micro Catheter.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K171268

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026